Yusuke Kamada

Yokohama, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

Proposal of an in vitro thrombus-growth model for evaluating anticoagulants.

Proposal of an in vitro thrombus-growth model for evaluating anticoagulants.

Journal: Drug discoveries & therapeutics
Published: June 26, 2022

Design and Synthesis of Novel Spiro Derivatives as Potent and Reversible Monoacylglycerol Lipase (MAGL) Inhibitors: Bioisosteric Transformation from 3-Oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl Moiety.

Design and Synthesis of Novel Spiro Derivatives as Potent and Reversible Monoacylglycerol Lipase (MAGL) Inhibitors: Bioisosteric Transformation from 3-Oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl Moiety.

Journal: Journal of medicinal chemistry
Published: July 30, 2021

Discovery of artificial VIPR2-antagonist peptides possessing receptor- and ligand-selectivity.

Discovery of artificial VIPR2-antagonist peptides possessing receptor- and ligand-selectivity.

Journal: Biochemical and biophysical research communications
Published: July 23, 2018

T-448, a specific inhibitor of LSD1 enzyme activity, improves learning function without causing thrombocytopenia in mice.

T-448, a specific inhibitor of LSD1 enzyme activity, improves learning function without causing thrombocytopenia in mice.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Published: June 26, 2018

Cholesterol Unbound RORγt Protein Enables a Sensitive Inverse Agonist Screening.

Cholesterol Unbound RORγt Protein Enables a Sensitive Inverse Agonist Screening.

Journal: Assay and drug development technologies
Published: June 07, 2018

Biochemical Properties of TAK-828F, a Potent and Selective Retinoid-Related Orphan Receptor Gamma t Inverse Agonist.

Biochemical Properties of TAK-828F, a Potent and Selective Retinoid-Related Orphan Receptor Gamma t Inverse Agonist.

Journal: Pharmacology
Published: January 25, 2018

Discovery of a novel B-cell lymphoma 6 (BCL6)-corepressor interaction inhibitor by utilizing structure-based drug design.

Discovery of a novel B-cell lymphoma 6 (BCL6)-corepressor interaction inhibitor by utilizing structure-based drug design.

Journal: Bioorganic & medicinal chemistry
Published: June 10, 2017

Discovery of a B-Cell Lymphoma 6 Protein-Protein Interaction Inhibitor by a Biophysics-Driven Fragment-Based Approach.

Discovery of a B-Cell Lymphoma 6 Protein-Protein Interaction Inhibitor by a Biophysics-Driven Fragment-Based Approach.

Journal: Journal of medicinal chemistry
Published: May 05, 2017

A pyridone derivative activates SERCA2a by attenuating the inhibitory effect of phospholamban.

A pyridone derivative activates SERCA2a by attenuating the inhibitory effect of phospholamban.

Journal: European journal of pharmacology
Published: May 01, 2017

Discovery of Novel 1,4-Diacylpiperazines as Selective and Cell-Active eIF4A3 Inhibitors.

Discovery of Novel 1,4-Diacylpiperazines as Selective and Cell-Active eIF4A3 Inhibitors.

Journal: Journal of medicinal chemistry
Published: March 31, 2017

Crystal Structure of a Human K-Ras G12D Mutant in Complex with GDP and the Cyclic Inhibitory Peptide KRpep-2d.

Crystal Structure of a Human K-Ras G12D Mutant in Complex with GDP and the Cyclic Inhibitory Peptide KRpep-2d.

Journal: ACS medicinal chemistry letters
Published: March 23, 2017

Discovery of a Kelch-like ECH-associated protein 1-inhibitory tetrapeptide and its structural characterization.

Discovery of a Kelch-like ECH-associated protein 1-inhibitory tetrapeptide and its structural characterization.

Journal: Biochemical and biophysical research communications
Published: March 10, 2017
Showing 1-12 of 21

Last Updated: 09/26/2026